ea0092ps3-27-03 | Thyroid Cancer clinical 3 | ETA2023
Minaldi Elisa
, Sabini Elena
, Prete Alessandro
, Agate Laura
, Bottici Valeria
, Brogioni Sandra
, Torregrossa Liborio
, Ugolini Clara
, Materazzi Gabriele
, Ribechini Alessandro
, Bruschini Luca
, Molinaro Eleonora
, Matrone Antonio
, Elisei Rossella
Objectives: Anaplastic thyroid cancer (ATC) is one of the deadliest cancers, with a median overall survival (OS) of 4 months and a disease-specific mortality of ˜100%. Although to date no effective treatment can cure the disease, some anecdotal cases achieved longer survival and very rarely the cure of the disease. Multimodal treatment with surgery, radiotherapy, multikinase inhibitors (MKI) could improve survival in ATC, particularly when surgery is not feasible.<p c...